Understanding how specific proteins influence eye development and potential blindness.
Molecular Determinants for WDR5-Driven Transcriptional Regulation at Lineage-Specifying Genes During Retinogenesis
This study is looking at how a protein called WDR5 helps control important genes for eye development, especially in the retina, to better understand what causes vision problems and blindness, which could lead to new treatments for people with retinal diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10953965 on NIH RePORTER |
What this research studies
This research investigates the role of WDR5, a chromatin modifier, in regulating genes that are crucial for eye development, particularly during the formation of the retina. By studying how WDR5 interacts with transcription factors like p53 and MAX, the research aims to uncover the mechanisms that lead to retinal defects and blindness. The approach involves using embryonic stem cells to explore these interactions and their implications for cell therapies aimed at treating retinal blindness. Patients may benefit from insights gained that could improve therapeutic strategies for retinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with retinal diseases or genetic conditions that affect eye development.
Not a fit: Patients with retinal conditions unrelated to the mechanisms being studied, or those who do not have a genetic predisposition to retinal defects, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for retinal blindness, potentially restoring vision for millions affected worldwide.
How similar studies have performed: Other research has shown promising results in understanding the role of chromatin modifiers in developmental processes, suggesting that this approach could yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Rao, Rajesh C. — University of Michigan at Ann Arbor
- Study coordinator: Rao, Rajesh C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.